How can we help you?
Get in touch with one of our Xperts.
Why we are unique
Full development support
Both strategic and operational
Speed up development programs and increase efficiency
Knowledge Transfer
Direct access to highly experienced consultants in various therapeutic areas and indications
Flexible deployment of experts
Cost and time effective
To meet the timeline, budget, regulatory and quality requirements
Vast network in the industry
Contract negotiation with CROs and C(D)MOs
Due diligence, valuation and venture capture
Our mission is to partner with you from early on to the very end.
Biomarkers in early drug development
The EMA glossary defines a biological marker, or biomarker, as ‘an objective and quantifiable measure of a physiological process, pathological process or response to a treatment (excluding measurements of how…
Evaluation of drug safety does not start at candidate nomination: Create value by de-risking early
Drug development is a daunting and difficult task where all the puzzle pieces need to click to result in an efficacious and safe treatment for patients. It is a…